Cellebrite DI (CLBT) Stock Forecast & Price Target
$2.99B
Market Cap
50.98
P/E
43.08
Forward P/E
52
Score
CLBT price $11.89 -0.03 -0.28%
Stocklytics score rationale: value 53, quality 58, growth 44.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| 171854000 | 194913000 | 246246000 | 270651000 | 325110000 | 401203000 | 475675000 |
Cellebrite DI Ltd. delivers specialized digital intelligence solutions crafted for legally authorized investigations. Their comprehensive DI platform enables users to efficiently gather, scrutinize, interpret, and oversee digital information throughout the investigative process. These essential tools are utilized in a wide array of scenarios, including cases involving child exploitation, homicides, counter-terrorism…
CLBT fair value $9.35. Price $11.89. Price is 27% above fair value.
Above fair value, and more expensive than usual. A larger premium than on 83% of days in the past 5 years.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 139.59M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.53% (beta 1.1). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 251.34M. Net debt -101.79M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | 0.09 | — | 145.83M |
| 2026-08-13 | 0.03 | 0.06 | 131.14M | 131.87M |
| 2026-05-14 | 0.04 | 0.05 | 128.30M | 127.01M |
| 2026-02-11 | 0.09 | 0.14 | 128.82M | 126.15M |
| 2025-11-12 | 0.08 | 0.09 | 126.03M | 122.98M |
| 2025-08-14 | 0.12 | 0.10 | 113.28M | 112.33M |
| 2025-05-14 | 0.10 | 0.05 | 107.55M | 109.32M |
| 2025-02-13 | 0.10 | 0.10 | 109.05M | 107.26M |
| 2024-11-06 | 0.14 | 0.09 | 106.86M | 102.06M |
| 2024-08-15 | 0.10 | 0.05 | 95.71M | 91.94M |
| 2024-05-23 | 0.08 | 0.06 | 89.58M | 85.34M |
| 2024-02-15 | 0.11 | 0.06 | 93.01M | 85.56M |
| 2023-11-14 | 0.10 | 0.05 | 84.18M | 82.13M |
| 2023-08-08 | 0.05 | 0.02 | 76.68M | 72.52M |
| 2023-05-10 | 0.03 | 0.03 | 71.23M | 69.44M |
| 2023-02-15 | 0.08 | 0.04 | 74.02M | 74.53M |
| 2022-11-17 | 0.01 | 0.02 | 71.67M | 72.13M |
| 2022-08-11 | 0.17 | 0.03 | 62.60M | 69.14M |
| 2022-05-12 | 0.01 | 0.02 | 62.38M | 62.58M |
| 2022-02-16 | 0.03 | 0.02 | 67.91M | 63.99M |
| 2021-11-10 | 0.08 | 0.02 | 65.89M | 59.25M |
| 2021-08-12 | 0.04 | 0.05 | 59.17M | 82.13M |
| 2021-08-06 | 0.02 | — | 53.28M | — |
| 2020-12-31 | 0.02 | — | 57.17M | — |
| 2020-09-30 | 0.04 | — | 53.24M | — |
| 2020-06-30 | 0.01 | — | 45.77M | — |
| 2020-03-31 | -0.09 | — | 38.73M | — |
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-16 | Barter David | Sell | 12.13K | $11.21 | 136.07K |
| 2026-09-24 | Ramji Shiven | Buy | 38.51K | — | — |
| 2026-09-17 | Utsumi Ryusuke | Buy | 15.19K | — | — |
| 2026-09-17 | Domnitz Yonatan | Buy | 15.19K | — | — |
| 2026-09-17 | CLAMMER ADAM | Buy | 15.19K | — | — |
| 2026-09-17 | Van Buren Brandon | Buy | 15.19K | — | — |
| 2026-09-17 | Richardson Troy | Buy | 15.19K | — | — |
| 2026-09-17 | Gruber Dafna | Buy | 15.19K | — | — |
| 2026-09-17 | Baudot-Trajtenberg Nadine | Buy | 15.19K | — | — |
| 2026-08-25 | Hogan Thomas E. | Sell | 25.30K | $11.29 | 285.71K |
| 2026-08-24 | GEE DAVID NICHOLAS | Sell | 4.32K | $11.36 | 49.11K |
| 2026-08-21 | Jewell Marcus | Sell | 12.56K | $11.24 | 141.22K |
| 2026-08-21 | GEE DAVID NICHOLAS | Sell | 2.20K | $11.24 | 24.71K |
| 2026-08-12 | Hogan Thomas E. | Sell | 139.71K | $15.39 | 2.15M |
| 2026-08-12 | Jewell Marcus | Sell | 411 | $16.07 | 6.60K |
| 2026-08-12 | GEE DAVID NICHOLAS | Sell | 230 | $16.07 | 3.70K |
| 2026-08-11 | Hogan Thomas E. | Buy | 339.48K | — | — |
| 2026-07-08 | Barter David | Sell | 41.73K | $16.38 | 683.42K |
| 2026-07-02 | Hogan Thomas E. | Sell | 103.19K | $15.76 | 1.63M |
| 2026-05-21 | GEE DAVID NICHOLAS | Sell | 2.24K | $13.10 | 29.38K |
| 2026-05-21 | GEE DAVID NICHOLAS | Sell | 3.43K | $13.15 | 45.09K |
| 2026-05-18 | Jewell Marcus | Sell | 12.66K | $12.77 | 161.66K |
| 2026-05-12 | GEE DAVID NICHOLAS | Sell | 228 | $13.01 | 2.97K |
| 2026-05-12 | Jewell Marcus | Sell | 383 | $13.01 | 4.98K |
| 2026-05-12 | Ramji Shiven | Buy | 423.55K | — | — |
| 2026-05-04 | Ramji Shiven | Other | 0 | — | — |
| 2026-03-18 | Domnitz Yonatan | Other | 0 | — | — |
| 2026-03-18 | Domnitz Yonatan | Other | 10.60K | — | — |
| 2026-03-18 | Utsumi Ryusuke | Other | 0 | — | — |
| 2026-03-18 | Utsumi Ryusuke | Other | 10.60K | — | — |
| 2026-03-18 | Tadmor-Eilat Zohar | Other | 0 | — | — |
| 2026-03-18 | Tadmor-Eilat Zohar | Other | 22.72K | $4.95 | 112.47K |
| 2026-03-18 | Tadmor-Eilat Zohar | Other | 28.24K | $11.51 | 325.00K |
| 2026-03-18 | Richardson Troy | Other | 0 | — | — |
| 2026-03-18 | Hogan Thomas E. | Other | 0 | — | — |
| 2026-03-18 | Hogan Thomas E. | Other | 500.00K | $7.39 | 3.69M |
| 2026-03-18 | Shavit Sigalit | Other | 0 | — | — |
| 2026-03-18 | Shavit Sigalit | Other | 31.42K | $12.73 | 399.99K |
| 2026-03-18 | Armon Ronnen | Other | 0 | — | — |
| 2026-03-18 | Armon Ronnen | Other | 60.61K | $6.60 | 400.00K |
| 2026-03-18 | Armon Ronnen | Other | 80.81K | $4.95 | 400.00K |
| 2026-03-18 | Armon Ronnen | Other | 43.44K | $11.51 | 499.99K |
| 2026-03-18 | Baudot-Trajtenberg Nadine | Other | 0 | — | — |
| 2026-03-18 | CAPELLAS MICHAEL D | Other | 0 | — | — |
| 2026-03-18 | Jewell Marcus | Other | 0 | — | — |
| 2026-03-18 | Jewell Marcus | Other | 301.51K | $7.96 | 2.40M |
| 2026-03-18 | Windham Holly B. | Other | 0 | — | — |
| 2026-03-18 | GEE DAVID NICHOLAS | Other | 0 | — | — |
| 2026-03-18 | GEE DAVID NICHOLAS | Other | 86.73K | $11.53 | 1000.00K |
| 2026-03-18 | Wade Christopher Michael | Other | 0 | — | — |
| 2026-03-18 | Van Buren Brandon | Other | 0 | — | — |
| 2026-03-18 | CLAMMER ADAM | Other | 0 | — | — |
| 2026-03-18 | CLAMMER ADAM | Other | 0 | — | — |
| 2026-03-18 | CLAMMER ADAM | Other | 0 | — | — |
Latest filed quarter: Q2 2026.
Institutions holding: 214, holders -20 vs prior quarter. Ownership 50.69%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| TRUE WIND CAPITAL MANAGEMENT, L.P. | 13.86M | 0 | 0.00% | 202.37M |
| VOSS CAPITAL, LP | 11.44M | 11.24M | +5620.94% | 167.05M |
| PERTENTO PARTNERS LLP | 8.00M | 1.34M | +20.15% | 116.87M |
| PHOENIX FINANCIAL LTD. | 6.18M | 2.00M | +47.83% | 90.24M |
| FMR LLC | 5.97M | -2.52M | -29.66% | 87.19M |
| BLACKROCK, INC. | 5.68M | 2.34M | +70.20% | 82.99M |
| NINE TEN CAPITAL MANAGEMENT LLC | 4.13M | 682.93K | +19.83% | 60.25M |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 3.27M | 1.08M | +49.45% | 47.69M |
| WELLINGTON MANAGEMENT GROUP LLP | 3.05M | 1.48M | +93.73% | 44.53M |
| CLAL INSURANCE ENTERPRISES HOLDINGS LTD | 2.77M | -400.00K | -12.61% | 40.49M |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 2.38M | -934.79K | -28.20% | 34.76M |
| MORGAN STANLEY | 2.19M | 112.68K | +5.41% | 32.03M |
| RENAISSANCE TECHNOLOGIES LLC | 2.15M | -710.40K | -24.83% | 31.39M |
| CAPITAL WORLD INVESTORS | 2.11M | 1.90M | +880.35% | 30.85M |
| CAPITAL INTERNATIONAL INVESTORS | 2.06M | -217.08K | -9.53% | 30.09M |
| PROGENY 3, INC. | 2.00M | 871.87K | +77.28% | 29.20M |
| PORTOLAN CAPITAL MANAGEMENT, LLC | 1.93M | -248.41K | -11.39% | 28.21M |
| WEISS ASSET MANAGEMENT LP | 1.92M | 23.51K | +1.24% | 28.08M |
| ASHFORD CAPITAL MANAGEMENT INC | 1.78M | 15.41K | +0.87% | 25.96M |
| BANK OF NEW YORK MELLON CORP | 1.74M | 410.45K | +30.78% | 25.46M |
| ORBIS ALLAN GRAY LTD | 1.71M | 1.71M | New | 24.93M |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.66M | -78.48K | -4.51% | 24.25M |
| RAYMOND JAMES FINANCIAL INC | 1.60M | 210.57K | +15.15% | 23.37M |
| PRINCIPAL FINANCIAL GROUP INC | 1.55M | -608.50K | -28.22% | 22.60M |
| PRAESIDIUM INVESTMENT MANAGEMENT COMPANY, LLC | 1.49M | -369.07K | -19.81% | 21.82M |
Consensus Buy from 9 analysts. Average price target $14.13, +18.9% versus the current price. Low $12.50. High $15.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $14.13 for Cellebrite DI (CLBT), 17.8% above the current price of $11.99. Of 9 analysts covering the stock, 9 rate it Buy or Strong Buy, 0 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $12.50 |
|---|---|
| Average | $14.13 |
| High | $15.00 |
The average is 17.8% above the current price of $11.99.
Of 9 analysts, 9 rate Cellebrite DI Buy or Strong Buy, 0 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $0.28, revenue $556.65 million. 2027, EPS $0.37, revenue $640.92 million.
The Stocklytics Score for CLBT is 52 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
$14.13 average, with a published range of $12.50 to $15.00.
The consensus is Buy from 9 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $0.28. The average revenue estimate is $556.65 million.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Cellebrite DI · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$2.99B
Market Cap
50.98
P/E
43.08
Forward P/E
52
Score